Identification of cfxA gene variants and susceptibility patterns in β-lactamase-producing Prevotella strains

Sodai Yokoyama1, Masahiro Hayashi2, Takatsugu Goto2

  • 1United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu City, Gifu, Japan.

Anaerobe
|December 29, 2022
PubMed
Abstract

Insights

Antimicrobial resistance in Prevotella species is rising, particularly to beta-lactams. This study identified key resistance genes like cfxA, tetQ, and ermF, and a novel CfxA7 variant, offering insights into multidrug resistance mechanisms.

Area of Science:

  • Microbiology
  • Genetics
  • Molecular Biology

Background:

  • Antimicrobial resistance in Prevotella species, especially to beta-lactams, is a growing concern.
  • Understanding the genetic mechanisms of resistance is crucial for combating its spread.

Purpose of the Study:

  • To investigate the mechanisms of antimicrobial resistance in Prevotella species.
  • To identify specific resistance genes and their prevalence in clinical isolates.

Main Methods:

  • Isolation and identification of Prevotella species from clinical specimens.
  • Determination of beta-lactamase production and minimum inhibitory concentrations (MICs) to ten antimicrobials.
  • Detection and sequencing of resistance genes (cfxA, tetQ, ermF, nim) and flanking regions.

Main Results:

  • 77.8% of Prevotella isolates produced beta-lactamases and harbored cfxA genes.
  • Prevalence of tetQ and ermF genes were 53.3% and 17.8%, respectively; nim gene was absent.
  • A novel cfxA variant, cfxA7, with an L155F substitution, was identified, showing lower MICs to certain beta-lactams compared to cfxA2 and cfxA3 variants.

Conclusions:

  • Amino acid substitutions in CfxA variants (CfxA2, CfxA3, CfxA7) may influence resistance to penicillins and cephalosporins.
  • Co-occurrence of cfxA-mobA, tetQ, and ermF genes increases the risk of multidrug-resistant Prevotella species emergence and spread.